Home > Financial Ratios > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
Core EBITDA Margin

    Back to All Ratios
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results

STRIDES PHARMA SCIENCE Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) 11.9511.259.406.17-0.40

What is the latest Core EBITDA Margin ratio of STRIDES PHARMA SCIENCE ?

The latest Core EBITDA Margin ratio of STRIDES PHARMA SCIENCE is 11.95 based on Mar2026 Consolidated results.
Year Core EBITDA Margin
Mar202611.95
Mar202511.25
Mar20249.40
Mar20236.17
Mar2022-0.40

How is Core EBITDA Margin of STRIDES PHARMA SCIENCE Trending?

Years Core EBITDA Margin % Change
Mar2026 11.95
6.22
Mar2025 11.25
19.68
Mar2024 9.4
52.35
Mar2023 6.17
Positive
Mar2022 -0.4 -

Other Financial Ratios of STRIDES PHARMA SCIENCE


Compare Core EBITDA Margin ratio of peers of STRIDES PHARMA SCIENCE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE ₹9,987.1 Cr -0.2% -8.5% 31.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,539.0 Cr -1.4% -6.6% 7.3% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 1.2% -2.6% 60% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,251.0 Cr -2% -6.1% 33% Stock Analytics
CIPLA ₹105,290.0 Cr -2.3% -5.8% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,752.6 Cr -1.1% 3.8% -5.5% Stock Analytics


STRIDES PHARMA SCIENCE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

-0.2%

-8.5%

31.8%

SENSEX

0.8%

-4.8%

-10.5%


You may also like the below Video Courses